Human papilloma virus in lung and esophageal carcinoma. Molecular pathology of Japan and Asia

肺癌和食道癌中的人乳头瘤病毒。

基本信息

  • 批准号:
    15406011
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2006
  • 项目状态:
    已结题

项目摘要

Human papilloma virus (HPV) is causally associated with carcinoma of the uterine cervix, genital organs, and anus. On the other hand, its relation to the lung and esophageal carcinomas has not been clarified yet, since the detection rates of HPV have been variable in the institutions and regions. In the present study, we investigated the HPV infection in lung and esophageal carcinomas in Japan and Asian countries in order to clarify the significance of HPV infection and to evaluate the regional differences.In situ hybridization and PCR detection of HPV-DNA were applied to the formalin-fixed and paraffin-embedded specimens of lung and esophageal carcinomas (total 483 samples), which were collected from four institutions of Japan (Tokyo, Kochi, Kagoshima and Okinawa), two institutions of Korea and each of Taiwan and Singapore.The presence of HPV-DNA was demonstrated in low frequencies, such as 6.9% of squamous cell carcinomas of the lung (12/174), 7.1% of adenocarcinomas of the lung (9/127) and 8.8% of esophageal carcinomas (16/182). The positive signals for HPV were sparsely distributed in some of the nuclei of the carcinoma cells in positive cases. The finding suggests that this sparse distribution is one of causes for the variability of the frequencies of the HPV infection in the previous reports.The positive frequencies in lung squamous cell carcinomas were 8.1, 8.6, 5.6 and 0% in Japan, Korea, Taiwan, and Singapore, respectively. The frequencies in lung adenocarcinomas were 5.0, 7.1, 13.3 and 0%, respectively. In esophageal carcinoma, the positive rates were 10.5, 8.0 and 6.4% in Japan, Korea, and Taiwan, respectively.When the frequencies were compared among the regions in Japan, the highest frequency was observed in that of esophageal carcinomas of Kagoshima (24.1%, 7/29), which was statistically significant. Otherwise, there was no regional difference in lung carcinomas.
人乳头状瘤病毒(HPV)与子宫宫颈,生殖器官和肛门的癌有因果关系。另一方面,尚未阐明其与肺和食道癌的关系,因为HPV的检测率在机构和地区的检测率是可变的。 In the present study, we investigated the HPV infection in lung and esophageal carcinomas in Japan and Asian countries in order to clarify the significance of HPV infection and to evaluate the regional differences.In situ hybridization and PCR detection of HPV-DNA were applied to the formalin-fixed and paraffin-embedded specimens of lung and esophageal carcinomas (total 483样本是从日本四个机构(东京,高知,kagoshima和冲绳),两个韩国机构以及台湾和新加坡每个机构收集的。在低频中,HPV-DNA的存在在低频中证明了HPV-DNA的存在,例如6.9%的鳞状细胞carcinomas(smocamous carcinomas of Lung(12/174),7.1%),7.1%),7.1%) (9/127)和8.8%的食管癌(16/182)。在阳性情况下,HPV的阳性信号稀疏分布在癌细胞的某些核中。该发现表明,这种稀疏分布是先前报告中HPV感染频率变化的原因之一。肺鳞状细胞癌的正频率分别为8.1、8.6、5.6、5.6和0%,分别在日本,韩国,台湾和新加坡。肺腺癌中的频率分别为5.0、7.1、13.3和0%。在食道癌中,日本,韩国和台湾的正率分别为10.5%,8.0%和6.4%。当日本地区比较频率时,在Kagoshima的食管食管癌中观察到了最高的频率(24.1%,7/29),这是统计学意义的。否则,肺癌没有区域差异。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kitagawa H et al.: "Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicity."Pathology International. 53. 823-827 (2003)
Kitakawa H 等人:“肺腺癌与非典型腺瘤性增生相关。一项特别涉及吸烟和癌症多重性的临床病理学研究。”国际病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lung adenocarcinoma associated with familial adenomatous polyposis. Clear cell carcinoma with beta-catenin accumulation accompanied by atypical adenomatous hyperplasia.
与家族性腺瘤性息肉病相关的肺腺癌。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Guo M;et al.;Xiao-Qin Ren;Goto A et al.
  • 通讯作者:
    Goto A et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUKAYAMA Masashi其他文献

FUKAYAMA Masashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUKAYAMA Masashi', 18)}}的其他基金

EB virus-associated gastric carcinoma. Molecular mechanisms of DNA hypermethylation and strategy for gastric cancer therapy.
EB病毒相关胃癌。
  • 批准号:
    20249022
  • 财政年份:
    2008
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
SV40 as a human oncogenic virus. Molecular epidemiology in Japan and Asia.
SV40 作为人类致癌病毒。
  • 批准号:
    19406006
  • 财政年份:
    2007
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Carcinogenesis of EB virus-associated gastric carcinoma. Mutual DNA-methylation of host and infective agent.
EB 病毒相关胃癌的致癌作用。
  • 批准号:
    18390110
  • 财政年份:
    2006
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pathogenesis of EB virus-associated neoplasms
EB病毒相关肿瘤的发病机制
  • 批准号:
    14207009
  • 财政年份:
    2002
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular epidemiology of human herpes virus 8-relafed diseases in Japan and Asia
日本和亚洲人类疱疹病毒8相关疾病的分子流行病学
  • 批准号:
    12576003
  • 财政年份:
    2000
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pulmonary Fibrosis and Carcinoma of the Lung : An Analysis of Genetic Abnormalities of Honeycombed Lesion and IPF-Related Lung Carcinoma.
肺纤维化和肺癌:蜂窝状病变和 IPF 相关肺癌的遗传异常分析。
  • 批准号:
    09470054
  • 财政年份:
    1997
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

靶向Treg-FOXP3小分子抑制剂的筛选及其在肺癌免疫治疗中的作用和机制研究
  • 批准号:
    32370966
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
原位矿化诱导中性粒细胞弹性蛋白酶ELANE介导Notch信号通路增效肺癌放疗的机制研究
  • 批准号:
    82373199
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
肿瘤来源外泌体circDOCK11靶向树突状细胞易化TRIM13对STING1的泛素化降解诱导肺癌免疫耐受研究
  • 批准号:
    82360505
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
EGLN3羟化酶通过调控巨噬细胞重编程促进肺癌细胞EMT及转移的机制研究
  • 批准号:
    82373030
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
超声联合载SIRP-α siRNA相变锰基纳米复合物增强非小细胞肺癌免疫治疗机制研究
  • 批准号:
    82371969
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..
C. TGF-B 配体和受体复合物的遗传性和体细胞改变
  • 批准号:
    8382108
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..
C. TGF-B 配体和受体复合物的遗传性和体细胞改变
  • 批准号:
    8504716
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..
C. TGF-B 配体和受体复合物的遗传性和体细胞改变
  • 批准号:
    8305784
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..
C. TGF-B 配体和受体复合物的遗传性和体细胞改变
  • 批准号:
    8704276
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..
C. TGF-B 配体和受体复合物的遗传性和体细胞改变
  • 批准号:
    7882978
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了